Collagen and Gelatin Market worth $1,083 million by 2026 – Growing incidence of diabetes, cancer, and chronic wounds

The Research Report on”Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular Disease, Dental, Surgical, Dural), End User (Hospitals, Surgical Centers) and Region – Global Forecast to 2026″, is projected to reach 1,083 million by 2026 from USD 772 million in 2021, at a CAGR of 7.0% during the forecast period.

Growth Driver: Growing incidence of diabetes, cancer, and chronic wounds;

Diabetes is an important target indication—it can increase the incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, requiring treatments and incurring exorbitant medical expenses. Nearly 25% of diabetics in the US develop foot ulcers during their lifetime, while ~15% of the diabetic population suffers from diabetic foot ulcers (DFUs). The increasing prevalence of DFUs is expected to drive the demand for regenerative medicine products like grafts and matrices. Thus, fueling the market growth.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr

Industry Segmentation In Detailed:

The bovine segment accounted for the largest share of the source segment in the collagen and gelatin market in 2020.

Based on source, the gelatin market is segmented into bovine, porcine, and others. The bovine source segment accounted for the largest share of both the collagen market and the gelatin market in 2020. This growth can be attributed to its increased usage in regenerative medicine owing to its high biocompatibility and biodegradability.

The orthopedic segment accounted for the largest share of the application segment in the collagen and gelatin market in 2020

Based on application, segmented into orthopedic, wound care, dental, surgical, cardiovascular, and other applications. The global gelatin market is segmented into orthopedic, wound care, and others. The orthopedic segment accounted for the largest share of both the collagen market and the gelatin market in 2020, mainly due to the increasing use of these biomaterials in orthopedic surgeries and the high demand for scaffolds for bone substitutes.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95663122&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr

Leading Key Players and Analysis:

The Key players in the collagen and gelatin markets include Integra LifeSciences (US), Royal DSM (Netherlands), CollPlant Biotechnologies (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions plc (UK), Collagen Matrix, Inc. (US), Symatese (France), GELITA AG (Germany), PB Leiner (Belgium), Smith & Nephew (UK), Zimmer Biomet (US).

Integra LifeSciences offers innovative solutions, including leading regenerative technologies, specialty surgical solutions, and orthopedic solutions. Its products are used for treating burn and deep tissue wounds and repairing the dura mater, nerves, and tendons. The Orthopedics and Tissue Technologies business segment offers soft tissue repair and tissue regeneration products, collagen products, and small bone fixation & joint replacement solutions. The company’s leading position in the market is attributed to its strong global footprint through distributors and agents.

Geographical Analysis in Detailed:

North America was the largest regional market for collagen and gelatin in 2020.

Geographically, segmented into North America, Europe, Asia Pacific, RoW. In 2020, North America accounted for the largest share of the collagen and gelatin market, followed by Europe & Asia Pacific. The market in North America is largely driven by the presence of key market players in the region coupled with the rising geriatric population.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=95663122&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.